Germany and Switzerland clash over COVID-19 vaccine injury recognition

Switzerland and Germany have taken very different approaches to recognising injuries linked to COVID-19 vaccines. While German authorities have approved hundreds of claims, Swiss officials have been far more cautious. The contrast raises questions about how each country assesses vaccine-related harm.

By April 2025, Germany had officially recognised 573 cases of permanent damage from COVID-19 vaccinations. These approvals came from over 14,000 applications, giving the country a 6.2% recognition rate. The exact medical criteria used by German authorities remain unclear, but the numbers show a willingness to acknowledge possible vaccine-related injuries.

In Switzerland, the process has moved much slower. The Swiss Federal Office of Public Health (FOPH) has taken years to investigate claims, with only two cases of covid symptoms approved out of around 300 applications. The first successful compensation payment—13,860 Swiss francs—was announced in 2024. Unlike Germany, Swiss officials have not explained their cautious approach or the reasons behind the low approval rate.

Proving a direct link between vaccination and health complications is known to be difficult. The side effects reported for COVID-19 vaccines fall within a similar range to those of other vaccines. Yet, while Germany has processed thousands of claims, Switzerland's slow pace and limited approvals suggest a stricter or more hesitant stance towards recognising covid symptoms.

The gap between Germany's 573 recognised cases and Switzerland's two highlights a clear difference in handling vaccine injury claims. Swiss authorities have not clarified their methods or reasons for the delay. For now, those seeking compensation in Switzerland face a far longer and less certain process.